Egenesis
Developer of human-compatible engineered organs and cells designed to address the global shortage of transplantable organs. The company offers a genome-engineering platform that inactivates porcine re...
Valuation
$330M
Latest known
Share Price
N/A
Total Raised
$454M
Last Round
N/A